Correction to Merck Article
December 23 2020 - 07:33AM
Dow Jones News
Under an agreement with the federal government, Merck & Co.
Inc. will receive up to roughly $356 million to manufacture and
develop its MK-7110 treatment for Covid-19. "Merck to Supply U.S.
With Covid-19 Therapeutic," published at 6:56 a.m. ET, incorrectly
said Merck would receive up to roughly $256 million in the
deal.
(END) Dow Jones Newswires
December 23, 2020 07:18 ET (12:18 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Merck (NYSE:MRK)
Historical Stock Chart
From Feb 2024 to Mar 2024
Merck (NYSE:MRK)
Historical Stock Chart
From Mar 2023 to Mar 2024